Aarti Drugs Limited(IN:AARTIDRUGS)
₹502.85+1.05 (+0.21%)
IN:AARTIDRUGS
Aarti Drugs Limited financials statements
₹502.85
At close:+1.05 (+0.21%)
Want to see IN:AARTIDRUGS full AI Analyst Report?
Aarti Drugs Limited (AARTIDRUGS) Financial Statements
3 Followers
Aarti Drugs Limited Financial Overview
Aarti Drugs Limited's market cap is currently ₹45.80B. The company's EPS TTM is ₹21.35; its P/E ratio is 19.99; and it has a dividend yield of 0.40%. Aarti Drugs Limited has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | ₹ 25.65B | ₹ 23.87B | ₹ 25.29B | ₹ 27.16B | ₹ 24.89B |
| Gross Profit | ₹ 7.50B | ₹ 8.45B | ₹ 8.51B | ₹ 3.69B | ₹ 3.89B |
| Operating Income | ₹ 2.42B | ₹ 7.33B | ₹ 2.69B | ₹ 2.65B | ₹ 2.88B |
| EBITDA | ₹ 3.12B | ₹ 2.87B | ₹ 3.25B | ₹ 3.12B | ₹ 3.44B |
| Net Income | ₹ 1.95B | ₹ 1.68B | ₹ 1.71B | ₹ 1.66B | ₹ 2.05B |
| Balance Sheet | |||||
| Cash & Short-Term Investments | ₹ 242.80M | ₹ 226.10M | ₹ 89.28M | ₹ 211.70M | ₹ 343.81M |
| Total Assets | ₹ 28.15B | ₹ 25.75B | ₹ 24.32B | ₹ 24.21B | ₹ 22.08B |
| Total Debt | ₹ 5.77B | ₹ 6.15B | ₹ 5.64B | ₹ 6.09B | ₹ 5.43B |
| Net Debt | ₹ 5.68B | ₹ 6.08B | ₹ 5.58B | ₹ 6.00B | ₹ 5.21B |
| Total Liabilities | ₹ 12.66B | ₹ 12.05B | ₹ 11.50B | ₹ 12.29B | ₹ 11.72B |
| Stockholders' Equity | ₹ 15.49B | ₹ 13.69B | ₹ 12.82B | ₹ 11.92B | ₹ 10.36B |
| Cash Flow | |||||
| Free Cash Flow | ₹ 490.90M | ₹ 674.20M | ₹ 1.33B | ₹ -304.70M | ₹ -823.39M |
| Operating Cash Flow | ₹ 2.22B | ₹ 2.45B | ₹ 3.59B | ₹ 1.34B | ₹ 696.36M |
| Investing Cash Flow | ₹ -1.75B | ₹ -1.65B | ₹ -2.24B | ₹ -1.64B | ₹ -1.49B |
| Financing Cash Flow | ₹ -451.40M | ₹ -821.20M | ₹ -1.36B | ₹ 165.40M | ₹ 920.25M |
Currency in INR

